1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Anti-NMDAR Encephalitis: new trials by email Literature Review of Anti-NMDAR Encephalitis trials Research Report on Anti-NMDAR Encephalitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis IA session, Rituximab - Anti-NMDAR Encephalitis | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 20 | 2021-06-23 | 2026-08-10 |
Anti-N-Methyl-D-Aspartate Receptor Encephalitis (1)
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Encephalitis (1) · Immune System Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Neurodegenerative Diseases (1) · Neuroinflammatory Diseases (1) · Paraneoplastic Syndromes (1) · Paraneoplastic Syndromes, Nervous System (1)
Rituximab (1)
Assistance Publique - Hôpitaux de Paris (1)
France (1)